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Summary. Aging is a complex set of events that involves the whole body. However, disruption of the central nervous 
system (CNS) function is the aspect of aging that elderly people worry about most. Aging has different effects on dif-
ferent aspects of neurological function. Our knowledge of the basic molecular mechanism of brain aging has signifi-
cantly improved over the past few decades. The rate of aging is not fixed, but is plastic and subject to modifications. 
The environmental factor proven to be very potent in modulating aging is reduced dietary intake. Dietary restriction 
(DR) is a vigorous nongenetic and nonpharmacological intervention that is known to delay ageing and increase an 
active and healthy lifespan in diverse species, from yeast to mammals. Additionally, DR can improve various brain 
functions, including learning and memory, synaptic plasticity and neurogenesis.
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Introduction
According to the World Health Organization (WHO), 
the population of elderly people in the world in the last 50 
years has tripled, and this trend will continue in the next 50 
years. The old population is growing faster than the total 
population in almost all regions of the world, with a conse-
quent increase in the incidence of age-related chronic dis-
eases, including neurodegenerative disorders. As a result, the 
costs of long-term care are set to sharply increase (Figueira 
et al. 2016), becoming a tremendous social and political 
problem. On the other hand, there has been an expansion 
of research related to the aging process, as well as to the de-
velopment of strategies that might slow aging and ensure a 
good quality of life for the elderly.
Aging is a phenomenon which is influenced by many 
factors, that happens at the molecular, cellular and tissue 
level and represents a complex set of events (Cummings 
2007), involving the whole body. However, disruption of the 
central nervous system (CNS) function is the aspect of aging 
that old people particularly worry about. It is believed that 
the brain represents one’s essence, and losing a grip of it is 
rarely understandable and acceptable. Changes in the brain 
that occur during aging have been studied since the 19th cen-
tury, but there is still a surprising amount of confusion as to 
what these changes are.
The term “normal brain aging” is used to describe the 
aging of the CNS in the absence of clinically diagnosed neu-
rodegenerative or psychiatric disease or related pathologies. 
However, the molecular changes that occur during normal 
aging of the brain significantly overlap with those observed 
in many diseases.
Aging has different effects on various aspects of neu-
rological function (Christensen 2001). Skills related to the 
speed of information processing, problem solving, inhibitory 
function, working memory, long-term memory and spatial 
orientation, all decrease with aging (Park and Reuter-Lorenz 
2009). In addition, a variety of motor functions, including 
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reaction time, speed of movement, hand and foot coordina-
tion, constantly decrease during the aging process. Changes 
in mood and perception of emotions are also present during 
the aging process. In contrast, abilities relating to general 
knowledge, implicit memory, understanding proverbs and 
professional expertise do not decrease with age, but over the 
years may even improve (reviewed in Christensen 2001; Park 
and Reuter-Lorenz 2009).
Our knowledge of the basic molecular mechanisms of 
aging has significantly expanded over the past few decades. 
Signaling pathways that appear to be the major regulators of 
aging have been identified. Recent studies have linked these 
signaling pathways to control of age-dependent brain pa-
thologies, indicating that disrupted regulation of fundamen-
tal aging mechanisms may contribute to the pathogenesis of 
neurodegenerative disorders. Better insight into the biology 
of the aging brain is achieved by using advanced techniques. 
Microarray technologies have enabled a global analysis of 
gene expression in model organisms and humans, and have 
led to the identification of evolutionarily conserved changes 
during aging. At the same time, advanced brain imaging 
techniques have allowed insights into the cognitive networks 
of the aging human brain.
Macroscopic changes in the aging brain 
Numerous postmortem studies of human brains have 
revealed a loss in brain weight of about 0.1% per year in 
people aged between 20 and 60 years. This loss is more se-
vere after the age of 60 (Ho et al. 1980). Brain volume also 
decreases during aging (Pfefferbaum et al. 1994) and this 
reduction shows some regional differences. The frontal and 
parietal cortex is affected more than the temporal and oc-
cipital cortex. The striatum is also affected (Resnick et al. 
2003). The reduction in brain volume increases by 0.1-0.2% 
per year between 30 and 50 years of age and 0.3-0.5% per 
year after the age of 70. The ventricular system expands and 
fills the space left by brain volume reduction. The leptomen-
ingeal complex slightly widens, while the subarachnoid space 
increases.
Microscopic changes in the aging brain
Understandings of the microscopic basis for the mac-
roscopic changes observed during brain aging have changed 
over the years. The main controversy relates to the loss of 
neurons. Initial studies that began in the 1950s examined the 
density of neurons in two-dimensional space and concluded 
that a substantial loss of neurons (10-60%) occurs with aging, 
depending on region and neuronal population. The neurons 
of the cerebral cortex (Henderson et al. 1980), the hippocam-
pus (Ball 1977) and Purkinje cells of the cerebellum (Hall et 
al. 1975) were believed to be particularly affected by aging. 
Recent studies based on stereological studies of neurons in 
three-dimensional space (Benes and Lange 2001) led to the 
conclusion that the loss of neurons in aging was undetect-
able, or relatively moderate (Hof and Morrison 2004). How-
ever, the size of neurons, reflecting the level of dendritic and 
axonal arborization, decreased during aging (Terry et al. 
1987), which consequently led to synapse number reduction.
Cellular and molecular changes in the aging brain
The key factor that plays an important role in aging 
brain is the high rate of oxidative metabolism providing 
enough energy for neuronal functioning. Mitochondrial 
oxidative metabolism inevitable leads to the formation of 
free radicals capable of damaging proteins, lipids and nucleic 
acids. DNA damage leads to reduced gene expression and/or 
formation of abnormal proteins that have to be eliminated. 
It was shown that genes involved in synaptic function and 
plasticity, vesicular transport, mitochondrial function and 
calcium homeostasis exhibit reduced expression after the 
age of 40. Antioxidative enzymes and growth factors, which 
are expected to inhibit the effects of oxidative damage, are 
altered due to changes in the effectiveness of their signal-
ing pathways or low production during aging (Mattson et 
al. 2004). Antioxidant defenses in the brain were, at best, 
relatively low. In contrast, the brain is rich in iron and un-
saturated fatty acids, which are particularly susceptible to 
peroxidation (Xiong et al. 2002). 
So far, the data have revealed the importance of neuro-
trophins in the treatment and prevention of numerous age-
related neurodegenerative diseases. Amongst them, brain-
derived neurotrophic factor (BDNF) is the best character-
ized as the modulator of normal brain aging (reviewed in 
Tapia-Arancibia et al. 2008). BDNF is a growth factor whose 
secretion is dependent on neuronal activity, and its level in 
the brain decreases with age. This factor is required for the 
change in density of dendritic spines that underlie learning 
and memory disorders, which are disturbed during senes-
cence (reviewed in Tapia-Arancibia et al. 2008). 
There is increasing evidence about the role of neu-
rotransmitters, especially serotonin, glutamate and dopa-
mine, in modulating normal brain aging. It is considered 
that serotonin plays a role in the normal aging brain, since 
its amount and the function of corresponding receptors are 
regulated by aging. In addition, serotonin and other age-
regulatory molecules, such as BDNF and insulin growth fac-
tor 1 (IGF-1) share the same signaling pathways (reviewed in 
Mattson et al. 2004). However, its full role in the process of 
extending life and maintaining health has yet to be clarified.
Glutamate, the predominant excitatory neurotransmit-
ter in the brain, is also a potential candidate as a brain-aging 
modulator. It facilitates the release of BDNF and is essential 
for long-term potentiation (LTP), synaptic plasticity, neuro-
genesis and neuronal survival depending on the activity and 
neural sprouting during development (reviewed in Mattson 
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2008). Through the increase in intracellular calcium and the 
effects of signal transduction pathways mediated by CREB 
and NFkB, glutamate modulates a rapid shifting of the den-
dritic architecture and long-term changes in the transcrip-
tion of different genes, including neurotrophins, which prob-
ably contributes to the age-dependent morphologic changes 
(reviewed in Mattson 2008).
Dopamine is another neurotransmitter than can modu-
late brain aging. It is involved in several age-related diseases, 
including Parkinson’s (PD) and Huntington’s (HD) disease. 
Additionally, the dopamine transporter (DAT) and dopa-
mine receptors D1 and D2 deteriorate with age (Backman 
et al. 2006).
Synaptic plasticity in the aging brain
Neuronal connections are not fixed, even in adulthood. 
They can change in response to both intrinsic and extrinsic 
stimuli. This plasticity allows the brain to compensate for 
injury and disease and to adapt to the changing environment, 
i.e. to learning processes and memory formation. Hence, it is 
the prerequisite for lifelong adaptive structural development 
(reviewed in Schaefers 2013). 
Neuroplasticity involves several levels. Functional 
plasticity on the level of the synapse involves changes in the 
quantity of transmitter release or receptor densities. Struc-
tural changes lead to an enlargement or reduction of the syn-
aptic contact area, the remodeling of whole synapses or even 
the retraction or extension of spines, branches, dendrites or 
axons. Finally, lifelong neurogenesis and synaptogenesis in 
the hippocampal dentate gyrus represent the most extraordi-
nary forms of neuroplasticity. In the course of physiological 
aging, plastic processes continue to decline. The number of 
synapses decreases and the morphology of synaptic contacts 
alters (Hof and Morrison 2004; Morrison and Baxter 2012). 
Additionally, a reduction occurs in the synthesis, receptor 
densities and binding sites of several neurotransmitters, 
including dopamine, serotonin, GABA and glutamate (re-
viewed in Schaefers 2013).
Brain metabolism during aging
The brain comprises about 2% of body mass, but utilizes 
25% of the total body glucose (Rossi et al. 2001). The greater 
part of glucose is used for energy generation through gly-
colysis and mitochondrial oxidative phosphorylation to sup-
port synaptic transmission. Neuronal glucose metabolism is 
complex. It includes mechanisms that control brain glucose 
uptake, such as insulin and the insulin signaling pathways. 
Brain glucose uptake comprises glucose transporter (GLUT)-
dependent glucose transport across the endothelium into 
astrocytes via GLUT1 and its transfer into neurons, mostly 
via GLUT3 and GLUT4, and subsequent glucose involve-
ment in the glycolytic pathway. The final step is the entry of 
glycolytic endpoints into the mitochondria that are further 
metabolized in the TCA cycle to generate ATP through oxi-
dative phosphorylation. 
Animal studies showed decreased brain glucose uptake 
with age along with a parallel decrease in neuronal GLUTs in 
Fischer 344 rats (reviewed in Yin et al. 2016). Aging induces 
changes in both glucose availability and the mitochondria 
energy-transducing capacity, including a decline in neuronal 
glucose uptake, decrease in electron transport chain activity, 
and increase in oxidant production (reviewed in Yin et al. 
2016).
Insulin and IGF-1signaling (IIS) play a crucial role in 
regulating and maintaining brain metabolic and cognitive 
function (de la Monte et al. 2005). Some of the key metabolic 
characteristics of the human longevity phenotype are a pre-
served insulin sensitivity, low insulin levels and reduced flux 
through the IIS (Harper 2014; van Heemst 2010). Insulin sig-
naling regulates mitochondrial function and its impairment 
underlies abnormalities in both mitochondrial function and 
biogenesis. Brain aging is associated with a reduced IIS path-
way entailing inactivation of the PI3K/Akt signaling in rats 
(Jiang et al. 2013). Overall, one can conclude that aging is 
associated with an increased risk of deteriorating systemic 
control of glucose and of brain glucose uptake (Craft 2006). 
Several preclinical and clinical studies seem to support a role 
for lowered brain glucose uptake in age-associated cognitive 
impairment (Cunnane et al. 2011).
In addition to glucose, cholesterol is essential for proper 
brain functioning. The brain contains 5-10 times more cho-
lesterol than any other organ. The blood-brain barrier (BBB) 
renders homeostasis of brain cholesterol independent of cir-
culating cholesterol, and consequently the brain produces 
cholesterol by de novo synthesis. Cholesterol biosynthesis is a 
complex process. The first steroid intermediate in cholesterol 
synthesis, lanosterol, can be converted to cholesterol through 
two alternative pathways: the Bloch pathway via desmosterol, 
a direct cholesterol precursor, and the Kandutsch-Russell 
pathway via lathosterol. Being a multifaceted molecule, it 
performs a plethora of functions. Cholesterol is an indis-
pensable membrane constituent, a cofactor for signaling 
molecules and a precursor for steroid hormones. The rela-
tionship between cholesterol and synaptic plasticity is firmly 
established (reviewed in Pfrieger and Ungerer 2011). A dis-
turbance in cholesterol homeostasis underlies many neuro-
degenerative diseases, and with aging represents a major risk 
factor for the development of such pathologies. Data regard-
ing brain cholesterol metabolism during aging are somewhat 
inconsistent (reviewed in Martin et al. 2010), suggesting that 
cholesterol metabolism in the different regions of the brain 
is not uniform. Our study revealed that cholesterol synthe-
sis, assessed by measurements of the concentrations of its 
precursors (lanosterol, lathosterol and desmosterol), was in-
creased with advanced age in extra cerebral tissues, while in 
the brain the rate of cholesterol biosynthesis was decreased 
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during aging. Major changes among brain regions were de-
tected in the hippocampus (Smiljanić et al. 2013).
Environmental factors and aging brain
The rate of aging is not predestined, but is plastic and 
subject to modifications. Among others, an environmental 
factor proven to be very potent in modulating aging is diet. 
For decades it has been known that a reduced daily food in-
take significantly extends the life of various species (Katewa 
and Kapahi 2009). 
Dietary restriction (DR) is a vigorous nongenetic, non-
pharmacological intervention that is known to delay age-
ing and increase the active and healthy lifespan of diverse 
species, from yeast to mammals (Katewa and Kapahi 2009). 
DR can improve various brain functions, including learning 
and memory, synaptic plasticity (Mladenović Djordjević et 
al. 2007, 2010; Smiljanić et al. 2015) and neurogenesis, to 
enhance the performance of rats and mice in various be-
havioral tasks and to counteract age-related molecular and 
cellular alterations that impair cognition (Duan et al. 2001). 
The protective role of reduced food intake may also be seen 
in Alzheimer’s disease (AD) and PD, as well as in other neu-
rodegenerative disorders (Mattson et al. 2002).
Dietary restriction and synaptic plasticity
Numerous clinical and epidemiological studies have 
confirmed the effects of DR on neuroplasticity and neuropro-
tection (for a review see Mattson et al. 2002). The impact of 
DR on age-associated alterations in gene expression is highly 
dependent on the class of gene and the brain regions (Park 
and Prolla 2005). DR induces transcriptional reprogramming 
of neural plasticity genes. Adams et al. (2008) found a signifi-
cant increase in synaptophysin (SPH) in old animals that had 
been subjected to DR compared to ad libitum (AL) controls, 
indicating synaptic changes following DR. Results from our 
laboratory showed that long-term DR applied in 6-month-
old rats can modulate age-related transcriptional changes of 
two presynaptic markers, GAP-43 and SPH, mostly in the 
cortex (Mladenović Djordjević et al. 2010). However, in the 
hippocampus lifelong dietary modulation increased the lev-
els of these proteins whose expression significantly decreases 
during aging. 
The beneficial effect of DR-promoted amelioration of 
age-related changes has been shown for other proteins as-
sociated with synaptic plasticity in the hippocampus (Park 
and Prolla 2005). Elevated GAP-43 and a-synuclein protein 
levels, in addition to SPH, suggest that a presynaptic com-
pensatory mechanism is activated in the hippocampus dur-
ing lifelong DR.
Dietary restriction and neurotrophins
One of proposed mechanisms accounting for the posi-
tive effects of DR includes enhanced neurotrophins expres-
sion. Literature data have verified the importance of BDNF 
in mediating DR-induced neuroprotective and metabolic 
effects (Duan et al. 2001). However, the data are inconsis-
tent. While it has been reported that intermittent fasting (IF) 
increases BDNF levels in the rodent hippocampus (Duan et 
al. 2001), no significant alterations or even decreases were 
observed in a model of reduced daily food intake (Andrade 
et al. 2006). Furthermore, while in rodents long-term DR 
prevents age-related deficits in BDNF-triggered processes, 
i.e. LTP and memory consolidation (Okada et al. 2003), some 
studies have failed to reveal any influence of DR on learning 
capacity (Hansalik et al. 2006), whereas others have pointed 
to a DR-related worsening of cognitive functions despite 
increased longevity (Yanai et al. 2004). Our results demon-
strated that long-term IF proved to be a potent modulator 
of the proBDNF/p75NTR and BDNF/TrkB systems in the 
rat cortex and hippocampus. It displayed both brain-region 
specific and age-dependent impacts on Bdnf transcription, 
BDNF protein synthesis/processing, TrkB receptor expres-
sion/glycosylation and p75NTR level (Smiljanić et al. 2015). 
Dietary restriction and glucose metabolism
AMP-activated protein kinase (AMPK) is the principal 
energy sensor in eukaryotic cells and acts to maintain cellu-
lar energy homeostasis (Hardie et al. 2012), and therefore has 
a critical role in neuronal maintenance and survival. Dagon 
et al. (2005) showed that a moderate limited daily feeding 
(LDF, 60% AL) increased hippocampal AMPK activity, in-
duced neurogenesis and improved cognition, but that severe 
LDF (40%) overactivated AMPK, reduced cognition and in-
duced neural apoptosis. However, a study performed in our 
laboratory showed that an IF feeding protocol decreased the 
expression of both AMPK and its phosphorylated form in 
the cortex of both middle-aged (12-month old) and aged 
(24-month old) groups, while LDF had no impact (unpub-
lished data). Hypoglycemia and activated AMPK were shown 
to regulate the expression of glucose transporters (GLUTs) 
in the brain (Cheng et al. 2003). Our study confirmed the 
influence of diverse DR approaches on AMPK expression in 
rat cortex and hippocampus. Consequently, the expression 
pattern of GLUT isoforms was affected following both IF and 
LDF. It should be emphasized that these changes strongly 
depended on the type of DR regime, as well as the age of the 
animals. Additionally, changes related to glucose metabolism 
following DR were more pronounced in the cortex compared 
to the hippocampus (unpublished data). 
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Dietary restriction and cholesterol metabolism
As mentioned above, the maintenance of brain choles-
terol homeostasis is a prerequisite for the proper function-
ing of the CNS (reviewed in Pfrieger and Ungerer 2011). 
There is considerable evidence that cholesterol in the brain 
was influenced by various dietary regimes, although overall 
cholesterol content remained unaffected (Mulas et al. 2005; 
Fon Tacer et al. 2010). However, a significant decrease in 
the levels of cholesterol precursors was detected even after 
short-term (20 h) fasting (Fon Tacer et al. 2010). Our results 
showed that both LDF and IF lowered cholesterol synthesis, 
but their influence varied strongly, depending on the brain 
region and age. IF displayed a greater impact on cholesterol 
precursors in the group of middle-aged animals (12-month-
old), while the influence of LDF was more prominent in old 
(24-month-old) animals. However, the most noteworthy dif-
ference between these feeding regimes was observed in the 
hippocampus of old rats in the case of the direct cholesterol 
precursor desmosterol. While LDF had no influence on des-
mosterol, IF promoted a pronounced increase in desmosterol 
concentration (unpublished data), The fact that desmosterol 
is a direct cholesterol precursor produced in the Bloch cho-
lesterol synthesis pathway which prevails in young individu-
als, suggests a switch to a less energy-consuming synthesis 
pathway in old animals exposed to IF (Smiljanić et al. 2014). 
The data strongly pointed to the ability of IF, but not LDF, 
to promote an energy-saving mechanism, thus revealing the 
capacity of the hippocampus to an age-related adaptive re-
sponse. 
Dietary restriction and frailty
The current anti-aging strategies are switching their 
focus from suppressing to promoting successful aging, in 
order to counterbalance the lifespan with the health span, the 
length of time spent free of the costly and harmful conditions 
of old age. Thus, optimal aging depends on both stimuli that 
promote a longer life and stimuli that diminish disease and 
morbidity (Gallagher et al. 2011). This is where the concept 
of frailty comes into focus, as an important tool in predicting 
negative health outcomes during aging. Frailty is referred to 
as a “multidimensional syndrome in aging” and is based on 
the combination of genetic, biological, physical, psychologi-
cal, social and environmental factors (Fulop et al. 2010); it 
can be evaluated using a frailty index (FI) (Parks et al. 2012). 
Frail individuals are at higher risk of accelerated physical 
and cognitive decline, disability and finally death (Fulop et 
al. 2010). In a recent study, our laboratory assessed the influ-
ence of diverse DR protocols (various duration and onset) 
on rat FI during aging. We observed that only early-onset, 
long-term DR decreased the FI, thus acting towards the im-
provement of the health span. These data clearly revealed the 
importance of the onset and/or duration of DR application 
in order to achieve the most beneficial effects (Todorovic et 
al. submitted data).
Conclusion
Ageing is thought to be a stochastic process combining 
predictable and random effects that lead to the accumula-
tion of unrepaired cellular damage, weakening cellular repair 
and compensatory mechanisms. Healthy aging depends on 
a combination of individual genetic factors, lifestyle and ex-
ternal environmental factors. Although brain cells are par-
ticularly vulnerable to the accumulated effects of ageing, the 
consequent changes are not inevitable. DR proved to be a 
noninvasive intervention that is able to attenuate age-relat-
ed alterations and promote the plastic capacity of the brain. 
However, to achieve the beneficial effects of DR, one should 
have a good estimation of the protocol used, when to start 
and most importantly, what one wants to achieve with such 
an intervention. 
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